XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows From Operating Activities:    
Net loss $ (4,225,578) $ (936,031)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and intangible asset amortization expense 24,731 54,973
Share-based compensation 280,739 51,055
Common stock issued for other expense 67,000
Provision for doubtful accounts 93,500 20,975
Provision for excess and obsolete inventory (5,332) (13,764)
Loss on disposal of assets 4,489 8,042
Amortization of ROU asset 76,917 149,597
Goodwill impairment charges 631,064
Changes in operating assets and liabilities:    
Accounts receivable 8,801 (19,740)
Inventory (230,966) (139,481)
Prepaid expenses and other 171,582 (119,296)
Accounts payable and accrued liabilities 910,523 (107,604)
Deferred revenue 1,595,644 (664,663)
Deposits (24,183)
Operating lease liability, net (65,157) (197,085)
Accrued equity compensation (14,065) 108,945
Net cash used in operating activities (743,108) (1,761,260)
Cash Flows From Investing Activities    
Purchases of property and equipment (30,348) (15,316)
Proceeds from the sale of property and equipment 2,250 1,500
Net cash used in investing activities (28,098) (13,816)
Cash Flows From Financing Activities    
Payment of dividends on series B preferred stock (35,984)
Redemption of series B preferred stock (1,980,000)
Cash proceeds on sale of common stock and warrants, net of expenses 21,711,131
Payments on convertible notes payable   1,259,874
Proceeds from issuances of convertible notes   514,200
Net cash provided by financing activities 19,695,147 1,774,074
Net change in cash and cash equivalents 18,923,941 (1,002)
Cash and cash equivalents, beginning of period 2,159,608 2,284,881
Cash and cash equivalents, end of period 21,083,549 2,283,879
Supplemental cash flow information:    
Interest paid
Income taxes paid
Non-cash investing and financing activities:    
Adjustment of carrying value of series B preferred stock to redemption value 2,262,847
Conversion of series B preferred stock 1,980,000
Subscription receivable - series B preferred stock 1,365,000
Options issued for accrued equity compensation 128,434
Accrued Series B dividend payable settled in shares of common stock 1,447
Deemed dividend on series B preferred stock arising on down round 439,999
Cashless exercise of prefunded warrants 2
Options issued for accrued equity compensation liability $ 78,938